
Mental Disorders
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40–120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder
by Thomas Shiovitz, MD; William M. Greenberg, MD; Changzheng Chen,